2,062
Views
6
CrossRef citations to date
0
Altmetric
Special Article

Medication adherence for persons with spinal cord injury and dysfunction from the perspectives of healthcare providers: A qualitative study

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon

References

  • DeVivo MJ, Chen Y. Trends in new injuries, prevalent cases, and aging with spinal cord injury. Arch Phys Med Rehabil. 2011;92(3):332–8. doi: 10.1016/j.apmr.2010.08.031
  • Hitzig SL, Tonack M, Campbell KA, McGillivray CF, Boschen KA, Richards K, et al. Secondary health complications in an aging Canadian spinal cord injury sample. Am J Phys Med Rehabil. 2008;87(7):545–55. doi: 10.1097/PHM.0b013e31817c16d6
  • Jensen MP, Kuehn CM, Amtmann D, Cardenas DD. Symptom burden in persons with spinal cord injury. Arch Phys Med Rehabil. 2007;88(5):638–45. doi: 10.1016/j.apmr.2007.02.002
  • Kroll T, Neri MT, Ho PS. Secondary conditions in spinal cord injury: results from a prospective survey. Disabil Rehabil. 2007;29(15):1229–37. doi: 10.1080/09638280600950603
  • Noreau L, Proulx P, Gagnon L, Drolet M, Laramee M-T. Secondary impairments after spinal cord injury. Am J Phys Med Rehabil. 2000;79(6):526–35. doi: 10.1097/00002060-200011000-00009
  • Cragg JJ, Noonan VK, Dvorak M, Krassioukov A, Mancini GBJ, Borisoff JF. Spinal cord injury and type 2 diabetes. Am Acad Neurol. 2013;81:1864–8.
  • Cragg JJ, Noonan VK, Krassioukov A, Borisoff J. Cardiovascular disease and spinal cord injury. Am Acad Neurol. 2013;81:723–8.
  • Kennedy P, Rogers BA. Anxiety and depression after spinal cord injury: a longitudinal analysis. Arch Phys Med Rehabil. 2000;81(7):932–7. doi: 10.1053/apmr.2000.5580
  • Jensen EK, Biering-Sorensen F. Medication before and after a spinal cord lesion. Spinal Cord. 2014;52(5):358–63. doi: 10.1038/sc.2014.20
  • The Multidisciplinary Association of Spinal Cord Injury Professionals. Management of the Older Person with a New Spinal Cord Injury. Middlesex: The Multidisciplinary Association of Spinal Cord Injury Professionals; 2010.
  • Guilcher SJT, Hogan ME, Calzavara A, Hitzig SL, Patel T, Packer T, et al. Prescription drug claims following a traumatic spinal cord injury for older adults: a retrospective population-based study in Ontario, Canada. Spinal Cord. 2018;56(11):1059–68. doi: 10.1038/s41393-018-0174-z
  • Hwang M, Zebracki K, Vogel LC. Medication profile and polypharmacy in adults with pediatric-onset spinal cord injury. Spinal Cord. 2015;53(9):673–8. doi: 10.1038/sc.2015.62
  • Kitzman P, Cecil D, Kolpek JH. The risks of polypharmacy following spinal cord injury. J Spinal Cord Med. 2017;40(2):147–53. doi: 10.1179/2045772314Y.0000000235
  • Patel T, Milligan J, Lee J. Medication-related problems in individuals with spinal cord injury in a primary care-based clinic. J Spinal Cord Med. 2017;40(1):54–61. doi: 10.1179/2045772315Y.0000000055
  • Siddall PJ. Management of neuropathic pain following spinal cord injury: now and in the future. Spinal Cord. 2009;47(5):352–9. doi: 10.1038/sc.2008.136
  • Cadel L, Everall AC, Hitzig SL, Packer TL, Patel T, Lofters AK, et al. Spinal cord injury and polypharmacy: a scoping review. Disabil Rehab. 2019. doi:10.1080/09638288.2019.1610085. [Epub ahead of print].
  • Marcum ZA, Gellad WF. Medication adherence to multidrug regimens. Clin Geriatr Med. 2012;28(2):287–300. doi: 10.1016/j.cger.2012.01.008
  • Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57–65. doi: 10.1517/14740338.2013.827660
  • Whalley Hammell K. Quality of life after spinal cord injury: a meta-synthesis of qualitative findings. Spinal Cord. 2007;45(2):124–39. doi: 10.1038/sj.sc.3101992
  • Hand BN, Krause JS, Simpson KN. Polypharmacy and adverse drug events among propensity score matched privately insured persons with and without spinal cord injury. Spinal Cord. 2018;56(6):591–7. doi: 10.1038/s41393-017-0050-2
  • Stern S, Merwin E, Holt F. Survival models of community tenure and length of hospital stay for the seriously mentally III: A 10-year perspective. Health Serv Outcomes Res Methodol. 2001;2(2):117–35. doi: 10.1023/A:1020154012982
  • Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705. doi: 10.1111/j.1365-2125.2012.04167.x
  • Canadian Pharmacists Association. Medication management [cited March 15, 2019]. Available from https://www.pharmacists.ca/education-practice-resources/professional-development/medication-management/.
  • Kripalani S, Henderson LE, Chiu EY, Robertson R, Kolm P, Jacobson TA. Predictors of medication self-management skill in a low-literacy population. J Gen Intern Med. 2006;21:852–6. doi: 10.1111/j.1525-1497.2006.00536.x
  • MacLaughlin EJ, Raehl CL, Treadway AK, Sterling TL, Zoller DP, Bond CA. Assessing medication adherence in the elderly. Drugs Aging. 2005;22(3):231–55. doi: 10.2165/00002512-200522030-00005
  • Hope CJ, Wu J, Tu W, Young J, Murray MD. Association of medication adherence, knowledge, and skills with emergency department visits by adults 50 years or older with congestive heart failure. Am J Health Syst Pharm. 2004;61:2043–9. doi: 10.1093/ajhp/61.19.2043
  • Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304–14. doi: 10.4065/mcp.2010.0575
  • Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. Geneva: World Health Organization; 2003.
  • Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–97. doi: 10.1056/NEJMra050100
  • Heisler M, Bouknight RR, Hayward RA, Smith DM, Kerr EA. The relative importance of physician communication, participatory decision making, and patient understanding in diabetes self-management. J Gen Intern Med. 2002;17:243–52. doi: 10.1046/j.1525-1497.2002.10905.x
  • Lee W, Noh Y, Kang H, Hong SH. The mediatory role of medication adherence in improving patients’ medication experience through patient-physician communication among older hypertensive patients. Patient Prefer Adherence. 2017;11:1119–26. doi: 10.2147/PPA.S137263
  • Lowes R. Patient-centered care for better patient adherence. Fam Pract Manag. 1998;5(3):46–57.
  • Patton MQ. Qualitative Research & Evaluation Methods. Thousand Oaks, CA: Sage; 2002.
  • de Casterle B D, Gastmans C, Bryon E, Denier Y. QUAGOL: a guide for qualitative data analysis. Int J Nurs Stud. 2012;49(3):360–71. doi: 10.1016/j.ijnurstu.2011.09.012
  • Miles MB, Huberman AM, Saldaña J. Qualitative Data Analysis: A Methods Sourcebook. Thousand Oaks, CA: Sage; 2014.
  • Berben L, Dobbels F, Engberg S, Hill MN, De Geest S. An ecological perspective on medication adherence. West J Nurs Res. 2012;34(5):635–53. doi: 10.1177/0193945911434518
  • Kenning C, Coventry PA, Gibbons C, Bee P, Fisher L, Bower P. Does patient experience of multimorbidity predict self-management and health outcomes in a prospective study in primary care? Fam Pract. 2015;32(3):311–6. doi: 10.1093/fampra/cmv002
  • Guilcher SJ, Craven BC, Lemieux-Charles L, Casciaro T, McColl MA, Jaglal SB. Secondary health conditions and spinal cord injury: an uphill battle in the journey of care. Disabil Rehabil. 2013;35(11):894–906. doi: 10.3109/09638288.2012.721048
  • McColl MA, Aiken A, McColl A, Sakakibara B, Smith K. Primary care of people with spinal cord injury. Can Fam Physician. 2012;58:e626–35.
  • Haggerty JL. Ordering the chaos for patients with multimorbidity. BMJ: Br Med J. 2012;345:e5915–6. doi: 10.1136/bmj.e5915
  • Boyd CM, Lucas GM. Patient-centered care for people living with multimorbidity. Curr Opin HIV AIDS. 2014;9(4):419–27. doi: 10.1097/COH.0000000000000073
  • American Pharmacists Association. Medication adherence. Available from https://www.pharmacist.com/measuring-adherence.
  • Brar Prayaga R, Jeong EW, Feger E, Noble HK, Kmiec M, Prayaga RS. Improving refill adherence in medicare patients with tailored and interactive mobile text messaging: pilot study. JMIR Mhealth Uhealth. 2018;6(1):e30. doi:10.2196/mhealth.8930.
  • Grenard JL, Munjas BA, Adams JL, Suttorp M, Maglione M, McGlynn EA, et al. Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. J Gen Intern Med. 2011;26(10):1175–82. doi: 10.1007/s11606-011-1704-y